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Introduction
Phenylketonuria (PKU) is the most widely inherited 
disorder of amino acid metabolism, in which mutations 
aff ecting phenylalanine hydroxylase (PAH) lead to the in-
hibition of the hydroxylation of the essential amino acid 
phenylalanine (Phe) to tyrosine (1), leading to accumula-
tion of the former in blood and tissues (2). Currently, the 
only way to prevent the disease from progressing and 
causing various sequelae is to adhere to a strict diet poor 
in Phe throughout the life of an individual, a task which 
is diffi  cult and not entirely protective from the detrimen-
tal eff ects of low Phe levels (3). Hence there is a great de-
mand for pharmacological approaches that can be used in 
the treatment of PKU today. One of them is alternative 
LNAA (large neutral amino acid) treatment, which aims 
to prevent Phe from entering into the brain and hopefully 
lower its cerebral amount by making LNAAs compete 
with Phe to cross blood-brain barrier (4).
Tetrahydrobiopterin (BH4) acts as the cofactor of PAH, 
mainly by increasing the residual PAH enzyme activity 
and stabilizing the enzyme tetramer in a multifactorial 
manner. Orally administered sapropterin dihydrochlo-
ride, a synthetic form of BH4, acts like BH4 in pharmaco-
logical doses in approx. one third of PKU patients (5). In 
recent years, studies on gene therapy using viral and oth-
er vectors have been conducted without any success due 
to diffi  culties in gene delivery and maintaining a stable 
expression. Plant phenylalanine ammonia lyase (PAL; EC 
4.3.1.24) enzyme has been suggested as a new oral thera-
py for the treatment of PKU (6).
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Summary
Enzyme substitution therapy with the phenylalanine ammonia lyase (PAL) is a new 
approach to the treatment of patients with phenylketonuria (PKU). This enzyme is respon-
sible for the conversion of phenylalanine to trans-cinnamic acid. We assessed the PAL en-
zyme of the endemic plant Cyathobasis fruticulosa (Bunge) Aellen. for its possible role in the 
dietary treatment of PKU. The enzyme was found to have a high activity of (64.9±0.1) U/
mg, with the optimum pH, temperature and buff er (Tris–HCl and l-phenylalanine) con-
centration levels of pH=8.8, 37 °C and 100 mM, respectively. Optimum enzyme activity 
was achieved at pH=4.0 and 7.5, corresponding to pH levels of gastric and intestinal juice, 
and NaCl concentration of 200 mM. The purifi cation of the enzyme by 1.87-fold yielded an 
activity of 98.6 U/mg. PAL activities determined by HPLC analyses before and aft er purifi -
cation were similar. Two protein bands, one at 70 and the other at 23 kDa, were determined 
by Western blot analysis of the enzyme. This enzyme is a potential candidate for serial pro-
duction of dietary food and biotechnological products.
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PAL acts by transforming Phe into a metabolically in-
ert substance called trans-cinnamic acid and trace amounts 
of ammonia. trans-Cinnamic acid is then converted to 
benzoic acid, which is renally excreted as hippurate. The 
enzyme does not use any cofactor (7). Although certain 
fungi and higher plants possess PAL activity, no animal 
has been shown to have this enzyme yet (8). Being one of 
several commercially available non-hydrolytic enzymes, 
plant PAL has been successfully utilized to treat certain 
neoplasms in mice as well as to measure serum levels of 
Phe in humans with PKU and diets low in Phe (9). Mod-
est reductions in Phe levels have been att ained in early 
trials of oral administration of PAL to humans. Some 
mouse models used a recombinant Anabaena variabilis 
PAL produced in Escherichia coli, which was subjected to 
genetic modifi cation to achieve high protease resistance 
and conjugated with polyethylene glycol (PEG) to achieve 
a lower immunogenicity (rAvPAL-PEG) (10). Research ef-
forts are ongoing to fi nd ways to orally administer PAL or 
encapsulate the enzyme in red blood cells (5).
In the secondary metabolism of plants, PAL initiates 
the biochemical phenylpropanoid biosynthetic pathway, 
in which it is one of the most challenging enzymes (11). 
Its activity is increased by some physical and chemical 
factors such as light, salt, excision, fungal cell surface elic-
itors and phytohormones (12), and its levels and activity 
are expected to rise under stress. Enzymatic reaction pro-
duces cinnamic acid, which acts as a precursor of many 
secondary substances including lignins, fl avonoid pig-
ments, UV protectants, plant hormones and phytoalexins; 
it is also a major source of total carbon in plants (13,14).
Cyathobasis fruticulosa (Bunge) Aellen. is a monotypic 
single species/single genus plant belonging to the genus 
Cyathobasis that is endemic to salt soils of Central Anatolia 
in Turkey. It is included in the tribe Salsoleae of the family 
Chenopodiaceae comprising a large variety of plants that 
contain alkaloids (15).
This study aims to evaluate the potential of a plant 
PAL enzyme to be used in biotechnology products for the 
treatment of PKU patients without any side eff ects. With 
high durability at environmental pH and temperature, 
and resistance to gastric and intestinal pH levels, these 
preparations may strengthen the eff ect of dietary thera-
pies when added to the diet of PKU patients. They may 
also have a role as orally administered preparations. An-
other objective of this study is to report the endemic Cyat-
hobasis fruticulosa (Bunge) Aellen. (Chenopodiaceae) as a 
natural product possessing a unique, high PAL activity.
Materials and Methods
Plant material
Cyathobasis fruticulosa naturally growing in fi elds rich 
in saline salts in Beypazarı, Ankara, Turkey, was collected 
in August 2011. The plant taxonomy was confi rmed by 
Dr. Zeki Aytaç (Gazi University, Ankara, Turkey). A 
voucher specimen was deposited at the Herbarium of 
Gazi University, Ankara, Turkey (voucher ID: ZA-10439). 
The plants were stored at –80 °C until use.
Extraction of PAL enzyme
The leaves were weighed, frozen in liquid nitrogen, 
and ground in a mortar. The fi nal pulverized powder was 
extracted in 50 mM Tris (Sigma-Aldrich, Steinheim, Ger-
many)-HCl (Merck, Darmstadt, Germany) buff er (pH=8.8) 
containing 10 mM 2-β-mercaptoethanol (Merck, Hohen-
brunn, Germany), 1 mM ethylenediaminetetraacetic acid 
(EDTA; Sigma-Aldrich) and 2.5 % polyvinylpyrrolidone-40 
(PVP-40; Sigma-Aldrich). The mixture was centrifuged at 
21 180×g for 20 min and the clear supernatant was desalt-
ed in aliquots using an Amicon Ultra-15 Centrifugal Filter 
Units with a membrane nominal mass limit of 50 kDa 
(Merck Millipore, Tullagreen Carrigtwohill, Ireland) and 
assayed for PAL activity under standard conditions. The 
aliquots were stored at –20 °C until use (16).
PAL activity assay and biochemical property analysis
Protein concentrations were determined by a dye- 
-binding Bradford method using Bradford reagent (Sigma - 
-Aldrich) and bovine serum albumin (Amresco, Cleve-
land, OH, USA) as the protein standard (17). PAL activity 
was assayed by measuring the trans-cinnamic acid forma-
tion at 290 nm using a UV-1800 UV-Vis spectrophotome-
ter (Shimadzu, Kyoto, Japan) and calculated using a stan-
dard trans-cinnamic acid, ≥99 % (Sigma-Aldrich) curve. 
The enzyme reaction mixture contained 100 mM Tris- 
-HCl, 40 mM l-phenylalanine, ≥98 % (Sigma-Aldrich), 
and an aliquot of the enzyme in a total volume of 1 mL at 
pH=8.8. The reaction was carried out at 37 °C for 30 min 
and terminated by the addition of 50 μL of 4 M HCl. PAL 
activity was expressed in U/mL and PAL specifi c activity 
was expressed in U/mg (16).
Determination of pH, temperature and buff er 
concentration
To determine the optimum pH, assays were per-
formed at 37 °C for 30 min using a buff er (100 mM Tris- 
-HCl and 40 mM l-phenylalanine) with various pH values 
(pH=2.0–12.0). For optimum temperature determination, 
assays were performed at pH=8.8 for 30 min at various 
temperatures (10–70 °C). To determine the optimum buf-
fer concentration, assays were performed at 37 °C and 
pH=8.8 for 30 min using Tris-HCl buff er (40 mM l-phe-
nylalanine) and various concentrations (5–500 mM) of 
Tris-HCl (18).
Simulated gastric and intestinal digestion
In vitro conditions simulating gastric and intestinal 
digestion were created. The reaction mixture was incu-
bated with 3 g/L of pepsin (Sigma-Aldrich), pH=2.0 or 4.0, 
for 30 min at 37 °C to mimic the gastric phase. The reac-
tion mixture was incubated with 1 g/L of pancreatin (Sig-
ma-Aldrich) and 0.30 % bile salt (Difco, Franklin Lakes, 
NJ, USA), pH=5.5, 7.5 or 9.5, for 30 min at 37 °C to simu-
late the intestinal phase (19).
Determination of PAL specifi c activity under diff erent 
NaCl concentrations
The PAL activity was determined in the presence of 
diff erent concentrations (50–300 mM) of NaCl (Sigma-Al-
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drich, Hunterdon, NJ, USA) in the reaction mixture (9). 
Assays were performed at 37 °C and pH=8.8 for 30 min 
using 100 mM Tris-HCl buff er and 40 mM l-phenylala-
nine.
Storage stability of PAL extract
PAL extract was stored at either room temperature or 
at 4 °C for 1–5 days and its activity was assayed. It was 
also stored at –20 °C for 1–12 months and then its activity 
was determined. Assays were performed at 37 °C and 
pH=8.8 for 30 min using 100 mM Tris-HCl buff er and 40 
mM l-phenylalanine. The relative activity (in %) of the 
extract was determined as a ratio of PAL specifi c activity 
in test conditions and PAL specifi c activity under opti-
mum conditions (pH=8.8, 37 °C and 100 mM Tris-HCl).
HPLC separation of PAL
The concentration of trans-cinnamic acid (PAL prod-
uct) formed was determined using diff erent volumes of 
PAL enzyme (100–300 μL), diff erent concentrations of 
substrate (40–160 mmol/L) and diff erent reaction times 
(30–90 min). The percentage of conversion of l-phenylala-
nine to trans-cinnamic acid was also determined under 
the following conditions: 300 μL of enzyme, 160 mmol/L 
of substrate and reaction time 60 min. The HPLC separa-
tion of the sample components was achieved both before 
and aft er the enzyme purifi cation. trans- Cinnamic acid 
detection was performed on an Agilent Technologies 
HPLC 1200 series (Santa Clara, CA, USA) equipped with 
a quaternary pump, a manual sampler and an ultraviolet/
visible (UV-Vis) detector. The column used was a 5 μm C18 
(250 mm×4.6 mm i.d.) from Advanced Chromatography 
Technologies (ACE, Aberdeen, Scotland, UK). The col-
umn was operated at 25 °C. The mobile phase consisted 
of 35 % H2O acetic acid and 65 % methanol (both from 
Merck, Darmstadt, Germany). The injection volume of all 
samples was 20 μL. Simultaneous monitoring was per-
formed at 280 nm and a fl ow rate of 1 mL/min (20).
Partial purifi cation of PAL
The enzyme was partially purifi ed in a two-step pro-
cedure involving ammonium sulfate (Merck, Darmstadt) 
precipitation and dialysis (21,22). The enzyme extract was 
brought to 60 % saturation by gradual addition of solid 
ammonium sulfate while stirring at 4 °C. Aft er 20 min of 
equilibration, the precipitated protein was obtained by 
centrifugation at 10 000×g at 4 °C for 30 min. The pellet 
was resuspended in 100 mM ice-cold Tris-HCl (pH=8.8). 
Enzyme activity and protein content were determined af-
ter separation of each fraction. The pretreated Slide-A- 
-Lyzer™ G2 Dialysis Cassett es, molecular mass cut-off  of 
20 000 (Thermo Fisher Scientifi c, Rockford, IL, USA), were 
used for dialysis of the enzyme collected and suspended 
aft er ammonium sulfate precipitation. The enzyme was 
dialyzed against 100 mM Tris-HCl (pH=8.8) at 4 °C for 
1–2 h. The buff er was changed, and the enzyme was dia-
lyzed for an additional 1–2 h. In the last step, dialysis was 
continued overnight at 4 °C in 100 mM Tris-HCl (pH=8.8) 
reaction buff er (more than 200-fold of the sample vol-
ume). The dialysate was centrifuged at 21 180×g for 20 min 
using an Amicon Ultra-15 Centrifugal Filter Unit (Merck 
Millipore). The partially purifi ed sample was assayed for 
protein content and enzyme activity.
SDS-PAGE of PAL
Sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) gels containing 4–10 % acrylamide 
(Merck, Hohenbrunn) were used and stained with Co o-
massie Brilliant Blue R-250 (Sigma-Aldrich) to visualize 
the PAL protein. The stacking gel (4 %) consisted of: 29.2 
% acrylamide and 8 % N,N’-methylene-bis-acryl amide 
(Sigma-Aldrich), 1.5 M Tris-HCl (pH=8.8), 10 % sodium 
dodecyl sulfate (SDS; Sigma-Aldrich), 10 % ammonium 
persulfate (APS; Sigma-Aldrich), N,N,N’,N’-tetramethyl-
ethylenediamine (TEMED; Sigma-Aldrich) and the sepa-
rating gel (10 %) consisted of: 30 % acrylamide-N,N’-
methylene-bis-acrylamide, 0.5 M Tris-HCl (pH=6.8), 10 % 
SDS, 10 % APS and TEMED. PageRuler™ Prestained Pro-
tein Ladder (10 to 170 kDa; Thermo Fisher Scientifi c, Viln-
ius, Lithuania) was used as a size standard (23).
Electrophoresis and Western blott ing
SDS-PAGE was performed on 4–12 % Bis-Tris gels 
(NuPAGE®; Thermo Fisher Scientifi c, Canoga Park, CA, 
USA) using a mini-cell gel system (XCell SureLock™; In-
vitrogen, Carlsbad, CA, USA). Following electrophoresis, 
proteins were stained with Coomassie Brilliant Blue R-250 
and destained with dye-destaining solution. Aft er separa-
tion, the proteins were transferred onto a polyvinylidine 
difl uoride (PVDF) membrane (0.2 μm pore size; NuPAGE®) 
using an iBlot® device (120 V, 1 h, room temperature; In-
vitrogen). All subsequent steps were carried out with a 
WesternBreeze® kit (Invitrogen) according to the manu-
facturer’s instructions. The kit contained blocking solu-
tion, the primary antibody diluents, secondary antibody 
(anti-rabbit) diluents, chromogenic substrate and wash-
ing solutions. The membrane was blocked for 30 min in 
the concentrated saline buff er solution containing deter-
gent and the Hammerstein casein solution, then incubat-
ed for 1 h with primary polyclonal PAL antibody (Tübitak 
MAM, Gebze, Kocaeli, Turkey), washed with the concen-
trated saline buff er solution and incubated for 30 min 
with alkaline phosphatase-conjugated anti-rabbit IgG an-
tibody. The excess of the secondary antibody was washed 
away three times and incubation continued with the 
5-bromo-4-chloro-3’-indolyphosphate p-toluidine salt 
(BCIP) and nitroblue tetrazolium chloride (NBT) sub-
strate solution for determination of alkaline phosphatase 
until purple bands developed on the membrane. The col-
our development was completed in 1 to 60 min. The 
membrane was rinsed twice with double distilled H2O for 
2 min and dried. The chromogenic band was visualized 
with UVP BioSpectrum 410 (Upland, CA, USA) imaging 
system (24,25).
Statistical analysis
All experiments were performed three times, and the 
mean value of each measurement was calculated. All re-
sults were reported as mean value±standard deviation 
(S.D.).
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Results and Discussion
Enzyme therapy with phenylalanine ammonia lyase 
(PAL) is complicated because it requires large amounts of 
purifi ed, highly specifi c PAL and the activation of im-
mune system with resultant immunological reaction 
against plant PAL. As such, repeated PAL administration 
leads to antibody production against it, resulting in both 
rapidly vanishing serum PAL activity and potentially det-
rimental allergic reactions. It was reported that in order to 
maintain therapeutic effi  cacy, PAL enzyme should stay in 
blood for an extended period (26). This issue has been for-
merly addressed by multitubular enzyme reactors with 
immobilized PAL (from Rhodotorula glutinis), which ena-
bled to remove 77 % of blood phenylalanine (Phe) rapid-
ly, without the enzyme entering circulation (27). Novel 
plant PALs displaying unique properties are still being 
actively sought.
The PAL activity of Cyathobasis fruticulosa is reported-
ly higher ((64.9±0.1) U/mg) than those of other plants, in-
cluding Bambusa oldhamii with a PAL activity of 0.19 U/mg 
(25), Fragaria × ananassa 44.5 U/mg (28), Cucurbita pepo 26.6 
U/mg (9), and Glycine max 0.43 U/mg (29). Plants are able 
to utilize light, carbon dioxide and various inorganic sub-
stances in an effi  cient manner for their relatively simple 
vital demands. Hence, they produce a variety of impor-
tant therapeutic substances for humans. Mass cultivation 
allows some plants with high nutritional potential and 
nonpathogenic composition to be grown in huge amounts 
as part of commercial production (30). Hence, plants 
could also be a very valuable commercial source of PAL 
enzyme; however, this enzyme should be further opti-
mized for use in human body.
PAL enzyme derived from C. fruticulosa has a specifi c 
activity of (54.9±0.1) U/mg at its optimum pH=8.8. A simi-
lar pH range of 7.5–10.6 was also reported for PAL from 
other plants such as Ustilago maydis (31), Nicotiana taba-
cum (32), Hordeum vulgare and Medicago sativa (33). Our 
study demonstrated a signifi cantly lower enzymatic acti-
vity (Fig. 1a) in acidic medium (pH=2.0, (45.3±0.0) U/mg), 
while enzymatic activity was improved at a slightly alka-
line pH and it was still present at pH=12 ((50.4±0.0) U/mg). 
Hence, it was concluded that isolated C. fruticulosa PAL is 
an alkaline enzyme. The enzyme lost its activity at 60 °C 
or above, and had activities of (44.5±0.1) and (40.9±0.1) U/mg 
at 10 and 50 °C, respectively. Its optimum temperature 
was 37 °C with the activity of (54.9±0.1) U/mg (Fig. 1b). 
Previous reports have indicated a temperature range of 
25 to 60 °C for other PAL enzymes derived from Musa sp. 
(34), Triticum aestivum (19), Ephedra sinica (35) and Vitis 
vinifera (36). Activities of (39.1±0.1) and (44.6±0.1) U/mg 
were recorded at 5 and 500 mM buff er concentrations, re-
spectively. PAL enzyme derived from C. fruticulosa had 
an optimum buff er concentration of 100 mM Tris-HCl 
((54.9±0.1) U/mg) (Fig. 1c), which is similar to what has 
been reported for other plant PAL enzymes, including 
those of Cucurbita pepo (9), Medicago sativa (21) and Glycine 
max (29).
The enzyme is susceptible to degradation by gastro-
intestinal proteases when orally administered, necessitat-
ing the advancement of novel ways to protect it from en-
zymatic proteolysis or acidic denaturation and to bring it 
into contact with enteric Phe (19). Gastric pH has a range 
between 1.5 and 2, and intestinal pH between 6 and 7.5, 
depending on dietary factors (37). As Phe enters entero-
circulation, enzyme development eff orts should give pri-
ority to oral formulations containing entrapped PAL, 
which enable the release of Phe from bloodstream into 
the gastrointestinal tract where it is metabolized but not 
reabsorbed (38). We therefore measured PAL activity of C. 
fruticulosa in artifi cial gastric and intestinal fl uids. The 
relative activity was not diff erent between pH=2.0 and 4.0 
in the simulated gastric phase and pH=5.5, 7.5 and 9.5 in 
the simulated intestinal phase (Fig. 2a). In a previous report , 
PAL of permeabilized R. glutinis cells was completely in-
activated by proteases found in duodenal juice within 30 
min (39); thus, our results indicated a more favourable 
























































































Fig. 1. Eff ect of: a) pH, b) temperature and c) Tris-HCl buff er 
concentration on phenylalanine ammonia lyase (PAL) activity
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Above optimal concentrations, NaCl may give rise to 
hysteresis followed by reduction of the enzymatic activi-
ty. Shielding of negatively charged amino acid residues 
and increasing hydrophobic interactions within the pro-
tein molecule are responsible for the stability of proteins 
(9). Thus, various NaCl concentrations were studied for 
their impact on PAL activity of C. fruticulosa at a pH=8.8 
(Fig. 2b). According to this analysis, the optimum NaCl 
concentration was determined to be 200 mM, similar to 
what was reported by Guo and Wang (40) and El-Shora 
(9). As NaCl concentration was increased to a range of 
250–300 mM, the relative activity was reduced (Fig. 2b).
Enzyme denaturation and reaction rates are altered 
by storage temperature. As shown in Fig. 3, enzyme activ-
ity of C. fruticulosa PAL was absent at 4 °C whereas it was 
stable at –20 °C and maintained so for 12 months. This re-
sult was in contrast to several reports that reported a 38 % 
loss in enzyme activity in 3 months at –20 °C (19), an al-
most 100 % loss in 7 days at 6 °C (29), and a 25 % loss in 
3.5 months at –10 °C (33).
The amount of formed trans-cinnamic acid was also 
determined by HPLC to measure the activity of C. fruticu-
losa PAL. A range of concentrations of 40–160 mmol/L 
produced mass concentrations of trans-cinnamic acid rang-
 ing between 3.3 and 3.7 ng/mL. A 90-minute reaction time 
and a volume of enzyme of 300 μL produced the greatest 
mass concentrations of trans-cinnamic acid (6.2 and 8.4 
ng/mL, respectively) determined by HPLC (Fig. 4).
Pre-purifi cation results showed that before and aft er 
enzymatic reaction, the l-phenylalanine was detected at 
concentrations of (160.0±2.3) and (124.0±1.8) mmol/L, re-
spectively, which corresponded to the conversion rate of 
l-phenylalanine to trans-cinnamic acid of (22.5±1.3) % 
and a post-reaction trans-cinnamic acid mass concentra-
tion of (12.3±1.0) ng/mL. Chromatographic separation of 
the reaction mixture was completed within less than 10 
min. l-Phenylalanine and trans-cinnamic acid had reten-
tion times of 2.7 and 5.6 min, respectively (Fig. 5).
Purifi cation yield of C. fruticulosa PAL from crude ex-
tract was 1.87-fold, which is lower than that of Medicago 
sativa (21). The fi nal specifi c activity of C. fruticulosa was 
98. 6 U/mg (Table 1), while lower values have been previ-
ously obtained for other species such as Cucurbita pepo 
(26.60 U/mg; 9) and Oryza sativa (4.625 nkat/mg; 41). SDS-
-PAGE of partially purifi ed PAL produces a single protein 
band corresponding to a molecular mass (M) of about 70 
kDa (Fig. 6). Other values of molecular masses were 80 
kDa for Bambusa oldhamii reported by Hsieh et al. (25) and 
84 kDa for Oryza sativa reported by Sarma and Sharma 
(41).
The trans-cinnamic acid mass concentration yielded 
by the partially purifi ed C. fruticulosa PAL was measured 
with HPLC. A substrate concentration of 40–160 mmol/L 
yielded a trans-cinnamic acid mass concentration of 3.1–
3.3 ng/mL. A 90-minute reaction time and an enzyme vol-
ume of 300 μL yielded the highest trans-cinnamic acid 
concentration (6.9 ng/mL) (Fig. 4).
Aft er partial purifi cation, l-phenylalanine was detect-
ed at concentrations of (160.0±2.6) and (122.0±2.2) mmol/L 







































































































Fig. 2. Eff ect of: a) simulating gastric pH (2 and 4) and intestinal 
phase pH (5.5, 7.5 and 9.5), and b) NaCl concentration in the re-
action mixture on phenylalanine ammonia lyase (PAL) activity
Fig. 3. The storage stability of phenylalanine ammonia lyase 
(PAL) at: a) room temperature (▪) and 4 °C (♦), and b) at –20 °C
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is equal to the l-phenylalanine to trans-cinnamic acid con-
version rate of (23.8±1.5) % and a post-reaction trans-cin-
namic acid mass concentration of (13.0±1.2) ng/mL. Chro-
matographic separation of the reaction mixture was 
completed within less than 10 min, with the retention 
times of l-phenylalanine and trans-cinnamic of 2.7 and 5.6 
min, respectively (Fig. 5). Pre- and post-purifi cation PAL 
activities measured by HPLC were in accordance with 
each other.
Western blot analysis of C. fruticulosa PAL was done 
by SDS-PAGE. The blott ed protein extracts of C. fruticulo-
sa were probed by anti-rabbit PAL antibodies, and a ma-
jor band was spott ed in the region corresponding to the 
molar mass (M) of the C. fruticulosa PAL subunit of 70 
kDa, as well as a minor band in the region corresponding 
to the M of the C. fruticulosa PAL subunit of 23 kDa (Fig. 
6).
Plants possess PAL activity that is regulated by a va-
riety of PAL-encoding genes which may be uniquely en-
coded only in some regions of plants or under certain en-
vironmental conditions (9). It has formerly been shown 
that various plants contain PAL enzymes with a heterote-
tramer structure (42). For instance, PAL from Rhizoctonia 
solani has an α-chain of 70 kDa and a β-chain of 90 kDa 
(43), while that from Triticum aestivum possesses a hete-
rotetramer structure with an α-chain of 75 kDa and a 
β-chain of 80 kDa (29). We also detected a minor band 
corresponding to a M≈23 kDa, suggesting that the C. fru-
ticulosa PAL enzyme also possesses a heterotetramer 
structure. A protein analysis will accurately establish such 
a structure.
Table 1. Partial purifi cation of phe nylalanine ammonia lyase 

















Crude extract 0.8±0.0 40.8±0.0 52.6±0.1 1 100
(NH4)2SO4 
precipitation 0.6±0.0 40.2±0.0 63.4±0.1 1.21 98.7












































































Fig. 5. Comparison of l-phenylalanine and trans-cinnamic acid amounts before and aft er enzymatic reaction, as a result of phenylala-
nine ammonia lyase (PAL) activity as determined by HPLC
Fig. 4. Eff ect of: a) substrate concentration, b) reaction time, and 
c) enzyme volume on mass concentration of trans-cinnamic acid 
(TCA)
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Conclusion
Blood phenylalanine (Phe) level of phenylketonuria 
(PKU) patients should be adequately lowered to non-tox-
ic concentrations by early initiated, strict dietary mea-
sures, which eff ectively averts neurological and function-
al sequelae, although this measure does not usually 
suffi  ce alone to keep Phe levels low for a lifetime. Hence, 
search for alternative therapies for PKU patients is ongo-
ing, such as large neutral amino acids (LNAA), sapro-
pterin, gene therapy, phenylalanine ammonia lyase (PAL), 
and others. Replacement of the culprit enzyme is an at-
tractive solution, but the relationship between repeated 
dosage, immunogenicity, and treatment effi  cacy should 
be meticulously studied before the administration of the 
enzyme in humans. As a candidate enzyme, PAL derived 
from Cyathobasis fruticulosa has a high activity that is not 
lost under a variety of physical and chemical conditions 
such as diff ering pH, temperature, and NaCl concentra-
tion. The advantage of the enzyme in question is that it is 
stable at body temperature (i.e. 37 °C) and immune to 
degradation by artifi cial gastric juices and intestinal fl u-
ids. Hence, it appears that it would be a useful candidate 
for mass production of dietary products by food industry 
and of biotechnological products by pharmaceutical com-
panies that develop treatments for PKU patients.
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